AGMB
AgomAb Therapeutics NV
8.60$
-1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in EUR.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -0.52 | -0.68 | -1.29 | -1.06 | |
| 0.00 | 0.00 | 0.01 | 0.00 | |
| 0.06 | 0.06 | 0.03 | 0.11 | |
| 0.04 | 0.11 | -0.04 | 0.01 | |
| 0.00 | 0.00 | 0.02 | 0.00 | |
| – | – | – | -0.68 | |
| -0.02 | 0.00 | 0.00 | -0.01 | |
| 1.04 | 2.19 | 2.67 | -0.01 | |
| -0.72 | 2.61 | 1.36 | -1.74 | |
| -0.52 | -0.68 | -1.31 | -1.06 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.